References
- Annapurna MM, Narendra A, Venkatesh B, et al. (2017). Stability indicating liquid chromatographic method for the determination of bimatoprost in ophthalmic solutions. J Chem Pharm Sci 10:778–81.
- Barrón-Hernández YL, Tosti A. (2017). Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia. Expert Opin Investig Drugs 26:515–22.
- BinJadeed H, Almudimeegh AM, Alomran SA, et al. (2021). A case of contact allergic dermatitis to topical minoxidil. Cureus 13:1–12.
- Björklund S, Pham QD, Jensen LB, et al. (2016). The effects of polar excipients transcutol and dexpanthenol on molecular mobility, permeability, and electrical impedance of the skin barrier. J Colloid Interface Sci 479:207–20.
- Carruthers J, Beer K, Carruthers A, et al. (2016). Bimatoprost 0.03% for the treatment of eyebrow hypotrichosis. Dermatol Surg 42:608–17.
- Choi N, Shin S, Song SU, et al. (2018). Minoxidil promotes hair growth through stimulation of growth factor release from adipose-derived stem cells. Int J Mol Sci 19:691–706.
- Cilurzo F, Casiraghi A, Selmin F, et al. (2015). Supersaturation as a tool for skin penetration enhancement. Curr Pharm Des 21:2733–44.
- Clausen ML, Slotved HC, Krogfelt KA, et al. (2016). Tape stripping technique for stratum corneum protein analysis. Sci Rep 6:19918.
- Cohen JL. (2010). Enhancing the growth of natural eyelashes: the mechanism of bimatoprost-induced eyelash growth. Dermatol Surg 36:1361–71.
- Cristiano MC, Froiio F, Mancuso A, et al. (2020). In vitro and in vivo trans-epidermal water loss evaluation following topical drug delivery systems application for pharmaceutical analysis. J Pharm Biomed Anal 186:1–7.
- Fagien S. (2010). Management of hypotrichosis of the eyelashes: focus on bimatoprost. Clin Cosmet Investig Dermatol 3:39–48.
- Fu D, Huang J, Li K, et al. (2021). Dihydrotestosterone-induced hair regrowth inhibition by activating androgen receptor in C57BL6 mice simulates androgenetic alopecia. Biomed Pharmacother 137:1–12.
- Ganem-Quintanar A, Lafforgue C, Falson-Rieg F, et al. (1997). Evaluation of the transepidermal permeation of diethylene glycol monoethyl ether and skin water loss. Int J Pharm 147:165–71.
- Garg T, Rath G, Goyal AK. (2015). Comprehensive review on additives of topical dosage forms for drug delivery. Drug Deliv 22:969–87.
- Houben RJ. (2020). Silicone crosspolymers: customising sensory feel. Semant Sch 22715289:1.
- Houschyar KS, Borrelli MR, Tapking C, et al. (2020). Molecular mechanisms of hair growth and regeneration: current understanding and novel paradigms. Dermatology 236:271–80.
- Kathe K, Kathpalia H. (2017). Film forming systems for topical and transdermal drug delivery. Asian J Pharm Sci 12:487–97.
- Kerure AS, Patwardhan N. (2018). Complications in hair transplantation. J Cutan Aesthet Surg 11:182–9.
- Khidhir KG, Woodward DF, Farjo NP, et al. (2013). The prostamide-related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias. FASEB J 27:557–67.
- Kumar T, Chaiyasut C, Suttajit M. (2011). Screening of steroid 5-reductase inhibitory activity and total phenolic content of Thai plants. J Med Plant Res 5:1265–71.
- Kwak S, Brief E, Langlais D, et al. (2012). Ethanol perturbs lipid organization in models of stratum corneum membranes: an investigation combining differential scanning calorimetry, infrared and 2H NMR spectroscopy. Biochim Biophys Acta 1818:1410–9.
- Macdiarmid J, Wilson JB. (2001). Separation of epidermal tissue from underlying dermis and primary keratinocyte culture. Methods Mol Biol 174:401–10.
- Mura P, Faucci MT, Bramanti G, et al. (2000). Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations. Eur J Pharm Sci 9:365–72.
- Orasan MS, Roman II, Coneac A, et al. (2016). Hair loss and regeneration performed on animal models. Clujul Med 89:327–34. 10.15386/cjmed-583 27547051
- Osborne DW, Musakhanian J. (2018). Skin penetration and permeation properties of Transcutol®-neat or diluted mixtures. AAPS PharmSciTech 19:3512–33.
- Osborne DW. (2011). Diethylene glycol monoethyl ether: an emerging solvent in topical dermatology products. J Cosmet Dermatol 10:324–9.
- Otto A, Wiechers JW, Kelly CL, et al. (2008). Effect of penetration modifiers on the dermal and transdermal delivery of drugs and cosmetic active ingredients. Skin Pharmacol Physiol 21:326–34.
- Purnamawati S, Indrastuti N, Danarti R, et al. (2017). The role of moisturizers in addressing various kinds of dermatitis: a review. Clin Med Res 15:75–87.
- Qi J, Garza LA. (2014). An overview of alopecias. Cold Spring Harb Perspect Med 4:1–14.
- Ritschel WA, Panchagnula R, Stemmer K, et al. (1991). Development of an intracutaneous depot for drugs. Binding, drug accumulation and retention studies, and mechanism of depot. Skin Pharmacol 4:235–45.
- Ro In B, Kim WJ, Kang JK, et al. (2021). Therapeutic effects of a new long-acting growth factor cocktail (Cellcurex™) injected using a microneedle on the scalp in patients with androgenetic alopecia: a split study. Glob Dermatol 7:1–4.
- Saceda-Corralo D, Pindado-Ortega C, Moreno-Arrones ÓM, et al. (2018). Health-related quality of life in patients with frontal fibrosing alopecia. JAMA Dermatol 154:479–80.
- Sallout BI, Al Wadi KA. (2009). Aphalangia possibly linked to unintended use of finasteride during early pregnancy. Ann Saudi Med 29:155–6.
- Smith S, Fagien S, Whitcup SM, et al. (2012). Eyelash growth in subjects treated with bimatoprost: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study. J Am Acad Dermatol 66:801–6.
- Spósito P, Mazzeti AL, De Oliveira FC, et al. (2017). Ravuconazole self-emulsifying delivery system: in vitro activity against Trypanosoma cruzi amastigotes and in vivo toxicity. Int J Nanomedicine 12:3785–99.
- Subedi L, Song S-Y, Jha SK, et al. (2021). Preparation of topical itraconazole with enhanced skin/nail permeability and in vivo antifungal efficacy against superficial mycosis. Pharmaceutics 13:622–37.
- Suchonwanit P, Thammarucha S, Leerunyakul K. (2019). Minoxidil and its use in hair disorders: a review. Drug Des Devel Ther 13:2777–86.
- Surber C, Knie U. (2018). Metamorphosis of vehicles: mechanisms and opportunities. pH of the skin: issues and challenges. Curr Probl Dermatol 54:152–65.
- Tan G, Xu P, Lawson LB, et al. (2010). Hydration effects on skin microstructure as probed by high-resolution cryo-scanning electron microscopy and mechanistic implications to enhanced transcutaneous delivery of biomacromolecules. J Pharm Sci 99:730–40.
- Tauchi M, Fuchs TA, Kellenberger AJ, et al. (2010). Characterization of an in vivo model for the study of eyelash biology and trichomegaly: mouse eyelash morphology, development, growth cycle, and anagen prolongation by bimatoprost. Br J Dermatol 162:1186–97.
- Varis T, Kivistö KT, Backman JT, et al. (2000). The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect. Clin Pharmacol Ther 68:487–94.
- Zaher H, Gawdat HI, Hegazy RA, et al. (2015). Bimatoprost versus mometasone furoate in the treatment of scalp alopecia areata: a pilot study. Dermatology 230:308–13.
- Zhang Q, Murawsky M, LaCount T, et al. (2018). Transepidermal water loss and skin conductance as barrier integrity tests. Toxicol In Vitro 51:129–35.
- Zhang YT, Shen LN, Wu ZH, et al. (2014). Comparison of ethosomes and liposomes for skin delivery of psoralen for psoriasis therapy. Int J Pharm 471:449–52.